Clinical Outcomes from Unselected “Real-World” Patients with Long Coronary Lesion Receiving 40 mm Biodegradable Polymer Coated Sirolimus-Eluting Stent

Table 2

Lesion and procedural characteristics.

Characteristics	Patients = 258/lesions = 278
Lesion location
Left anterior descending, (%)	100 (36.0%)
Right coronary artery, (%)	141 (50.7%)
Left circumflex, (%)	37 (13.3%)
Left main, (%)	0 (0%)
ACC/AHA lesion classification
C, (%)	278 (100%)
Number of diseased vessels
Single-vessel disease, (%)	165 (64.0%)
Double-vessel disease, (%)	79 (30.6%)
Triple-vessel disease, (%)	14 (5.4%)
Total occlusion, (%)	61 (21.9%)
Total number of stents
Number of stents per patient; (mean ± SD, mm)	1.1 ± 0.3
Number of stents per lesion; (mean ± SD, mm)	1.0 ± 0.1
Average stent length; (mean ± SD, mm)	40.0 ± 0.0
Average stent diameter; (mean ± SD, mm)	3.1 ± 0.4

ACC/AHA: American College of Cardiology/American Heart Association.